Renovion, Inc.
Pharmaceutical company · Chapel Hill, North Carolina, United States
Renovion, Inc. is a pharmaceutical company headquartered in Chapel Hill, North Carolina, United States. Its earliest recorded incorporation is in 2013. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2023.
Renovion at a glance
What does Renovion do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $1.8 million in total (2020). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $15 million sold (2023).
Frequently asked questions about Renovion
Where is Renovion headquartered?
Renovion, Inc. is headquartered in Chapel Hill, North Carolina, United States.
What does Renovion do?
Renovion, Inc. is a pharmaceutical company.
When was Renovion founded?
The earliest incorporation on record for Renovion, Inc. is in 2013, according to public company registers.
Similar companies
- Tenax Therapeutics, Inc.Chapel Hill, North Carolina, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.